Is HLOSF or RYLD a better dividend investment in 2026?

HLOSF currently yields 90.91% with a 5% 5-year dividend growth rate. RYLD yields 12.14% with 5% growth. The better choice depends on your goal: HLOSF offers higher current income.

What is the dividend yield difference between HLOSF and RYLD?

HLOSF has a forward dividend yield of 90.91% ($2.00/share annually). RYLD yields 12.14% ($1.81/share annually). The yield gap is 78.77 percentage points.

Home › Compare › HLOSF vs RYLD

HLOSF vs RYLD: Dividend Comparison 2026

HLOSF yields 90.91% · RYLD yields 12.14%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 HLOSF wins by $2.62M in total portfolio value

INVESTMENT

TIME HORIZON10 years

HLOSF

● Live price

90.91%

Share price

$2.20

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$2.67M

Annual income

$842,999.04

Full HLOSF calculator →

RYLD

● Live price

12.14%

Share price

$14.95

Annual div

$1.81

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$44.5K

Annual income

$2,587.35

Full RYLD calculator →

Portfolio growth — HLOSF vs RYLD

📍 HLOSF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	HLOSF	RYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, HLOSF + RYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

HLOSF pays

RYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HLOSF

Annual income on $10K today (after 15% tax)

$7,727.27/yr

After 10yr DRIP, annual income (after tax)

$716,549.18/yr

RYLD

Annual income on $10K today (after 15% tax)

$1,031.60/yr

After 10yr DRIP, annual income (after tax)

$2,199.25/yr

At 15% tax rate, HLOSF beats the other by $714,349.94/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HLOSF + RYLD for your $10,000?

HLOSF: 50%RYLD: 50%

100% RYLD50/50100% HLOSF

Portfolio after 10yr

$1.36M

Annual income

$422,793.19/yr

Blended yield

31.18%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on HLOSF right now

HLOSF

Analyst Ratings

Buy

Consensus: Buy

Altman Z

1.9

Piotroski

2/9

RYLD

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HLOSF buys

RYLD buys

No recent congressional trades found for HLOSF or RYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricHLOSFRYLD

Forward yield	90.91% ✓	12.14%
Annual dividend / share	$2.00 ✓	$1.81
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$2.67M	$44.5K ✓
Annual income after 10y	$842,999.04 ✓	$2,587.35
Total dividends collected	$2.36M	$18.8K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: HLOSF vs RYLD ($10,000, DRIP)

Year	HLOSF Portfolio	HLOSF Income/yr	RYLD Portfolio	RYLD Income/yr	Gap
1← crossover	$19,791	$9,090.91	$11,914	$1,213.65	+$7.9K → HLOSF
2	$37,991	$16,814.71	$14,099	$1,351.30	+$23.9K → HLOSF
3	$70,817	$30,166.17	$16,580	$1,494.55	+$54.2K → HLOSF
4	$128,326	$52,552.16	$19,384	$1,642.61	+$108.9K → HLOSF
5	$226,308	$88,999.24	$22,535	$1,794.70	+$203.8K → HLOSF
6	$388,835	$146,685.82	$26,063	$1,950.00	+$362.8K → HLOSF
7	$651,597	$235,543.05	$29,995	$2,107.69	+$621.6K → HLOSF
8	$1,066,101	$368,892.48	$34,361	$2,266.99	+$1.03M → HLOSF
9	$1,704,801	$564,073.19	$39,194	$2,427.12	+$1.67M → HLOSF
10	$2,667,136	$842,999.04	$44,525	$2,587.35	+$2.62M → HLOSF

HLOSF vs RYLD: Complete Analysis 2026

HLOSF — Stock

Healios K.K. engages in the research and development, manufacture, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States. The company is also developing cellular and tissue-based products comprising HLCR011 and HLCR012 that are iPSC regenerative medicines for the treatment of age-related macular degeneration; HLCL041, an iPSC regenerative medicine for the treatment of metabolic liver disease; and HLCM051, a regenerative medicine for treatment of ischemic stroke and acute respiratory distress syndrome, as well as HLCN061 for treating solid tumors. Healios K.K. has a joint research agreement with the Hyogo Medical University on cancer immunotherapies for mesothelioma using eNK cells. The company was formerly known as Retina Institute Japan, K.K. and changed its name to Healios K.K. in September 2013. Healios K.K. was incorporated in 2011 and is headquartered in Tokyo, Japan.

Full HLOSF Calculator →

RYLD — ETF

The Global X Russell 2000 Covered Call ETF (RYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Russell 2000 BuyWrite Index.

Full RYLD Calculator →

📬

Get this HLOSF vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HLOSF vs SCHD HLOSF vs JEPI HLOSF vs O HLOSF vs KO HLOSF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.